Back
Day Range
$4.17
$4.25
52-Week Range
$3.78
$5.00
Volume
1,200
50D / 200D Avg
$4.33
/
$4.45
Prev Close
$4.17
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | -9.2 | 3.7 |
| Net Margin % | -14.4 | 3.8 |
| Rev Growth 5Y % | 2.4 | 10.0 |
| D/E | 0.8 | 0.2 |
Key Takeaways
Revenue grew 2.39% annually over 5 years — modest growth
Earnings declined -186.42% over the past year
Negative free cash flow of -15.37B
PEG of 0.10 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 25.25%
Growth
Revenue Growth (5Y)
2.39%
Revenue (1Y)-22.86%
Earnings (1Y)-186.42%
FCF Growth (3Y)N/A
Quality
Return on Equity
-9.22%
ROIC-5.86%
Net Margin-14.39%
Op. Margin-20.11%
Safety
Debt / Equity
0.81
Current Ratio1.16
Interest Coverage-42.90
Valuation
P/E Ratio
-0.11
P/B Ratio0.01
EV/EBITDAN/A
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -22.86% | Revenue Growth (3Y) | -1.87% |
| Earnings Growth (1Y) | -186.42% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2.39% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 33.07B | Net Income (TTM) | -4.76B |
| ROE | -9.22% | ROA | -4.54% |
| Gross Margin | 65.73% | Operating Margin | -20.11% |
| Net Margin | -14.39% | Free Cash Flow (TTM) | -15.37B |
| ROIC | -5.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.81 | Current Ratio | 1.16 |
| Interest Coverage | -42.90 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | -0.11 | P/B Ratio | 0.01 |
| P/S Ratio | 0.02 | PEG Ratio | 0.10 |
| EV/EBITDA | N/A | Dividend Yield | 0.03% |
| Market Cap | 508.67M | Enterprise Value | 25.42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 33.07B | 42.87B | 34.34B | 51.08B | 30.09B |
| Net Income | -4.76B | 5.51B | 3.77B | 14.51B | 6.89B |
| EPS (Diluted) | -38.43 | 43.92 | 30.22 | 116.79 | 55.52 |
| Gross Profit | 21.74B | 31.25B | 25.46B | 40.62B | 22.27B |
| Operating Income | -6.65B | 7.53B | 4.98B | 19.93B | 8.27B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 104.86B | 102.23B | 94.94B | 97.13B | 73.78B |
| Total Liabilities | 57.42B | 45.75B | 42.53B | 46.05B | 35.23B |
| Shareholders' Equity | 47.04B | 56.18B | 52.16B | 50.88B | 38.38B |
| Total Debt | 38.11B | 23.30B | 22.80B | 18.10B | 18.10B |
| Cash & Equivalents | 13.20B | 18.76B | 13.28B | 30.73B | 26.26B |
| Current Assets | 51.06B | 57.58B | 47.80B | 62.19B | 48.55B |
| Current Liabilities | 43.99B | 30.14B | 35.76B | 42.05B | 29.03B |